The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
107117305 10711730 5 F 201411 20160719 20150114 20160726 PER US-ASTRAZENECA-2015SE01029 ASTRAZENECA 31287.00 DY F Y 66.20000 KG 20160726 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
107117305 10711730 1 PS NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral Y U BAVWB 204655 22.3 MG CAPSULE QD
107117305 10711730 2 SS NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral Y U BAVWB 204655 22.3 MG CAPSULE QD
107117305 10711730 3 SS NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral Y U BAVWB 204655 22.3 MG CAPSULE QD
107117305 10711730 4 SS NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral 20 MG PURPLE TABLET ONE IN MORNING Y U N3204 204655 TABLET
107117305 10711730 5 SS NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral 20 MG PURPLE TABLET ONE IN MORNING Y U N3204 204655 TABLET
107117305 10711730 6 SS NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral 20 MG PURPLE TABLET ONE IN MORNING Y U N3204 204655 TABLET
107117305 10711730 7 SS PRILOSEC OMEPRAZOLE MAGNESIUM 1 Oral U U 0 CAPSULE
107117305 10711730 8 SS PRILOSEC OMEPRAZOLE MAGNESIUM 1 Oral U U 0 CAPSULE
107117305 10711730 9 C REMERON MIRTAZAPINE 1 0
107117305 10711730 10 C KLONOPIN CLONAZEPAM 1 0
107117305 10711730 11 C 20 BILLION PROBIOTICS 2 0
107117305 10711730 12 C DMANNOSE 2 0
107117305 10711730 13 C ULTRA ALOE 2 0
107117305 10711730 14 C MAGNESIUM MAGNESIUM 1 0
107117305 10711730 15 C ASPIRIN. ASPIRIN 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
107117305 10711730 1 Gastrooesophageal reflux disease
107117305 10711730 2 Dyspepsia
107117305 10711730 3 Gastrooesophageal reflux disease
107117305 10711730 4 Gastrooesophageal reflux disease
107117305 10711730 5 Dyspepsia
107117305 10711730 6 Gastrooesophageal reflux disease
107117305 10711730 7 Gastrooesophageal reflux disease
107117305 10711730 8 Dyspepsia
107117305 10711730 12 Urinary tract infection

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
107117305 10711730 Asthenia
107117305 10711730 Diarrhoea
107117305 10711730 Dizziness
107117305 10711730 Drug ineffective
107117305 10711730 Dyspnoea
107117305 10711730 Headache
107117305 10711730 Intentional product misuse
107117305 10711730 Muscular weakness
107117305 10711730 Neck pain
107117305 10711730 Pain in extremity
107117305 10711730 Paraesthesia
107117305 10711730 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
107117305 10711730 1 20141205 0
107117305 10711730 2 20141205 0
107117305 10711730 3 20141205 0
107117305 10711730 4 20160621 0
107117305 10711730 5 20160621 0
107117305 10711730 6 20160621 0
107117305 10711730 7 2001 0
107117305 10711730 8 2001 0